Milestone Payments by Cephalon. 8.3.1. (a) Cephalon shall pay to Ambit the following milestone payments within thirty (30) days of the achievement thereof, each of which shall be payable (i) one time in respect of a Collaboration Clinical Candidate designated as such pursuant to Section 8.1 after […***…] from the Effective Date and directed against the First Collaboration Target within the Field, provided that no milestone payments shall be payable in respect of such Collaboration Clinical Candidate if Cephalon has made or is required to make the milestone payments set forth in Section 8.3.1(b), (ii) one time in respect of a Collaboration Clinical Candidate directed against the Second Collaboration Target, (iii) one time in respect of the first Mutant Form Candidate directed against the First Collaboration Target within the Field, (iv) one time in respect of the second Mutant Form Candidate directed against the First Collaboration Target within the Field, and (v) one time in respect of a Collaboration Clinical Candidate directed against the First Collaboration Target outside the Field: Milestone Amount (US$) […***…] $[…***…] ***Confidential Treatment Requested […***…] $[…***…] […***…] $[…***…] […***…] $[…***…] […***…] $[…***…] […***…] $[…***…] […***…] $[…***…] […***…] $[…***…] […***…] $[…***…] […***…] $[…***…] […***…] $[…***…] […***…] $[…***…]
Appears in 3 contracts
Samples: Collaboration Agreement (Ambit Biosciences Corp), Collaboration Agreement (Ambit Biosciences Corp), Collaboration Agreement (Ambit Biosciences Corp)
Milestone Payments by Cephalon. 8.3.1. 8.3.1 (a) Cephalon shall pay to Ambit the following milestone payments within thirty (30) days of the achievement thereof, each of which shall be payable (i) one time in respect of a Collaboration Clinical Candidate designated as such pursuant to Section 8.1 after […***…] from the Effective Date and directed against the First Collaboration Target within the Field, provided that no milestone payments shall be payable in respect of such Collaboration Clinical Candidate if Cephalon has made or is required to make the milestone payments set forth in Section 8.3.1(b), (ii) one time in respect of a Collaboration Clinical Candidate directed against the Second Collaboration Target, (iii) one time in respect of the first Mutant Form Candidate directed against the First Collaboration Target within the Field, (iv) one time in respect of the second Mutant Form Candidate directed against the First Collaboration Target within the Field, and (v) one time in respect of a Collaboration Clinical Candidate directed against the First Collaboration Target outside the Field: Milestone Amount (US$) […***…] $[…***…] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] **** Certain information on this page has been omitted and filed separately with the Commission. Confidential Treatment Requested treatment has been requested with respect to the omitted portions. […***…] $[…***…] […***…] $[…***…] […***…] $[…***…] […***…] $[…***…] […***…] $[…***…] […***…] $[…***…] […***…] $[…***…] […***…] $[…***…] […***…] $[…***…] […***…] $[…***…] […***…] $[…***…]
Appears in 1 contract
